表紙
市場調查報告書

美國的顯影劑及放射性醫藥品市場分析:2019年

Contrast Agents and Radiopharmaceuticals | Market Analysis | US | 2019

出版商 Millennium Research Group - DRG 商品編碼 140085
出版日期 內容資訊 英文 72 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的顯影劑及放射性醫藥品市場分析:2019年 Contrast Agents and Radiopharmaceuticals | Market Analysis | US | 2019
出版日期: 2018年07月23日內容資訊: 英文 72 Pages
簡介

美國市場的顯影劑及放射性醫藥品的成長,由於CEUS及PET治療的顯影劑的使用擴大而受推動。可是,根據不同模式釓及放射線暴露對健康影響的不穩定要素使成長將多少受到限制。還有轉向價值為基礎的照護(患者的偏好、價值觀為基礎醫療),支撐提供最精密鮮明影像的診斷方法的有效利用,另一方面也阻礙其利用。

本報告提供美國的顯影劑及放射性醫藥品市場整體,及各分類市場概要與分析,競爭分析等。

第1章 顯影劑及放射性醫藥品市場

  • 市場亮點
  • 市場定義
  • 市場預測資料
  • 整體的市場趨勢
  • 競爭亮點
  • 市場佔有率
  • 市場發展
  • 競爭因素與策略

第2章 放射性醫藥品市場

  • 市場亮點
  • 市場定義
  • 市場預測資料
    • SPECT
    • PET
  • 整體的市場趨勢
  • 競爭亮點
  • 市場佔有率
  • 競爭因素與策略

第3章 CT及X光掃描顯影劑市場

  • 市場亮點
  • 市場定義
  • 市場預測資料
    • CT
    • 心血管用X光掃描
    • 一般的X光掃描
  • 整體的市場趨勢
  • 競爭亮點
  • 市場佔有率
  • 競爭因素與策略

第4章 MRI顯影劑市場

  • 市場亮點
  • 市場定義
  • 市場預測資料
  • 整體的市場趨勢
  • 競爭亮點
  • 市場佔有率
  • 競爭因素與策略

第5章 超音波顯影劑市場

  • 市場亮點
  • 市場定義
  • 市場預測資料
  • 整體的市場趨勢
  • 競爭亮點
  • 市場佔有率
  • 競爭因素與策略

調查方法

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: M360RP0010

Growth in the US market for contrast agents and radiopharmaceuticals will be driven by the expanded use of imaging agents in CEUS and PET procedures. However, the market will be somewhat limited by the continued concern over gadolinium and radiation exposure in certain modalities, while the shift to value-based care will hinder the use of some procedures while supporting the use of those that provide the most accuracy and clarity of visualization.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for contrast agents and radiopharmaceuticals in the US across a 10-year period.

The FDA recently expanded approval for the use of CEUS in radiology procedures.

  • What types of procedures does this approval extend to? Which additional procedures could be approved in the future?
  • Which contrast agents received FDA approval?
  • How will competitors that do not have FDA approval react?

Looming concerns over the effects of gadolinium retention will negatively affect the use of contrast-enhanced MRI.

  • How are ACOs, health networks, and physicians responding to the recent findings on gadolinium retention?
  • What are the key differences between linear and macrocyclic GBCAs, and how will market demand for these products shift going forward?
  • Will other imaging modalities cannibalize contrast-enhanced MRI procedures?

While less concerning than in the past, radiation dose concerns still exert a limiting effect on procedure volumes for some imaging modalities.

  • How are US radiologists responding, and what methods are they using to ensure image quality?
  • Which procedures are being cannibalized by other modalities that do not require radiation for image acquisition?

The SPECT radiopharmaceuticals industry is taking precautionary measures to insulate itself from the shortening supply of Mo-99 and Tc-99.

  • What novel technology is showing promise that could help with global supply of Tc-99?
  • How will the transition from HEU to LEU reactors affect ASPs in the US market?

Table of Contents

Table of Contents

Tables and Figures

Executive Summary

Version History

1. Contrast Agent and Radiopharmaceutical Market

  • 1.1. Market Highlights
  • 1.2. Market Definitions
  • 1.3. Market Forecast Data
  • 1.4. General Market Trends
  • 1.5. Competitive Highlights
  • 1.6. Market Shares
  • 1.7. Competitive Factors and Strategies
  • 1.8. Market Developments

2. Radiopharmaceutical Market

  • 2.1. Market Highlights
  • 2.2. Market Definitions
  • 2.3. Market Forecast Data
  • 2.4. General Market Trends
  • 2.5. Competitive Highlights
  • 2.6. Market Shares
  • 2.7. Competitive Factors and Strategies

3. CT and X-Ray Contrast Agent Market

  • 3.1. Market Highlights
  • 3.2. Market Definitions
  • 3.3. Market Forecast Data
  • 3.4. General Market Trends
  • 3.5. Competitive Highlights
  • 3.6. Market Shares
  • 3.7. Competitive Factors and Strategies

4. MRI Contrast Agent Market

  • 4.1. Market Highlights
  • 4.2. Market Definitions
  • 4.3. Market Forecast Data
  • 4.4. General Market Trends
  • 4.5. Competitive Highlights
  • 4.6. Market Shares
  • 4.7. Competitive Factors and Strategies

5. Ultrasound Contrast Agent Market

  • 5.1. Market Highlights
  • 5.2. Market Definitions
  • 5.3. Market Forecast Data
  • 5.4. General Market Trends
  • 5.5. Competitive Highlights
  • 5.6. Market Shares
  • 5.7. Competitive Factors and Strategies

Methodology

  • Core Country Coverage Methodology
  • Supplemental Country Coverage Methodology

Appendix: Acronyms and Initialisms

Appendix: Bibliography

Tables and Figures

  • Table 1: Factors Impacting the Contrast Agent and Radiopharmaceutical Market, by Product Type, US
  • Figure 1: Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2017--2027
  • Table 2: Contrast Agent and Radiopharmaceutical Market Landscape, US (USD), 2018 and 2027
  • Table 3: Competitive Factors and Strategies, by Product Type, US
  • Table 4: Contrast Agent and Radiopharmaceutical Market Share Rankings, by Product Type, US, 2018
  • Table 5: Companies Mentioned
  • Table 6: Recent Events in the Contrast Agent and Radiopharmaceutical Market, US
  • Table 7: Emerging Products for the Contrast Agent and Radiopharmaceutical Market, US
  • Table 8: Contrast Agent and Radiopharmaceutical Procedures and Products Covered, US
  • Table 9: Version History
  • Table 10: Factors Impacting the Contrast Agent and Radiopharmaceutical Market, by Product Type, US
  • Figure 2: Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2017--2027
  • Table 11: Contrast Agent and Radiopharmaceutical Procedures, by Product Type, US, 2017--2027
  • Table 12: Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2017--2027
  • Figure 3: Contrast Agent and Radiopharmaceutical Revenue Market Shares, US, 2018
  • Table 13: Contrast Agent and Radiopharmaceutical Revenue Market Shares, by Product Type, US, 2018
  • Table 14: Competitive Factors and Strategies, by Product Type, US
  • Table 15: Recent Events in the Contrast Agent and Radiopharmaceutical Market, US
  • Table 16: Emerging Products for the Contrast Agent and Radiopharmaceutical Market, US
  • Figure 4: Radiopharmaceutical Market, by Product Type, US (USD), 2017--2027
  • Table 17: Radiopharmaceutical Market, by Product Type, US (USD), 2017--2027
  • Table 18: Radiopharmaceutical Market Growth, by Product Type, US, 2018--2027
  • Table 19: Nuclear Medicine System Installed Base, by Product Type, US, 2017--2027
  • Figure 5: Radiopharmaceutical Revenue Market Shares, US, 2018
  • Table 20: Radiopharmaceutical Revenue Market Shares, by Product Type, US, 2018
  • Table 21: Competitive Factors and Strategies, US
  • Figure 6: CT and X-Ray Contrast Agent Market, by Product Type, US (USD), 2017-- 2027
  • Table 22: CT and X-Ray Contrast Agent Market, by Product Type, US (USD), 2017-- 2027
  • Table 23: CT and X-Ray Contrast Agent Market Growth, by Product Type, US, 2018-- 2027
  • Table 24: CT and X-Ray System Installed Base, by Product Type, US, 2017--2027
  • Table 25: CT Contrast Agent Market, by Procedure Type, US (USD), 2017--2027
  • Table 26: CT Contrast Agent Market Growth, by Procedure Type, US, 2018--2027
  • Figure 7: CT and X-Ray Contrast Agent Revenue Market Shares, US, 2018
  • Table 27: CT and X-Ray Contrast Agent Revenue Market Shares, US, 2018
  • Table 28: Competitive Factors and Strategies, US
  • Figure 8: MRI Contrast Agent Market, by Procedure Type, US (USD), 2017--2027
  • Table 29: MRI Contrast Agent Market, by Procedure Type, US (USD), 2017--2027
  • Table 30: MRI Contrast Agent Market Growth, by Procedure Type, US, 2018--2027
  • Table 31: MRI System Installed Base, US, 2017--2027
  • Figure 9: MRI Contrast Agent Revenue Market Shares, US, 2018
  • Table 32: MRI Contrast Agent Revenue Market Shares, US, 2018
  • Table 33: Competitive Factors and Strategies, US
  • Figure 10: Ultrasound Contrast Agent Market, US (USD), 2017--2027
  • Table 34: Ultrasound Contrast Agent Market, US (USD), 2017--2027
  • Figure 11: Ultrasound Contrast Agent Revenue Market Shares, US, 2018
  • Table 35: Ultrasound Contrast Agent Revenue Market Shares, US, 2018
  • Table 36: Competitive Factors and Strategies, US
  • Table 37: Acronyms and Initialisms
Back to Top